Hepatitis C and steatosis: a reappraisal.

@article{Lonardo2006HepatitisCA,
  title={Hepatitis C and steatosis: a reappraisal.},
  author={Amedeo Lonardo and Paola Dr Loria and Luigi Elio Adinolfi and Nicola Carulli and Giuseppe Ruggiero},
  journal={Journal of viral hepatitis},
  year={2006},
  volume={13 2},
  pages={73-80}
}
The overall prevalence of steatosis in patients with Hepatitis C virus (HCV) chronic infection is 55.5% (range 34.8-81.2%). This is a two to threefold increase compared with the prevalence of steatosis in chronic hepatitides because of other aetiologies and of the figures expected on the grounds of a steatosis-HCV chance association. HCV genotype 3 (HCV-3) has specific epidemiological features; furthermore, as compared with HCV-non-3 genotypes, it is associated with a higher prevalence (74.1%vs… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 53 extracted citations

The Impact of Host Metabolic Factors on Treatment Outcome in Chronic Hepatitis C

Gastroenterology research and practice • 2012
View 5 Excerpts
Highly Influenced

Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists • 2018
View 1 Excerpt

Similar Papers

Loading similar papers…